slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 218,371-218,400
Pages 10,126
Rows per page 30
Component
218,371-218,400 of 303,780
16
Includes a photo of the Heydar Aliyev rig.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
17
Includes segment-specific commentary for Maersk Supply Service and Maersk Tankers.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
19
The slide provides a brief narrative update on Svitzer's Q3 2015 performance.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
21
The slide is a dense text-based executive summary of financial results.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
23
Maersk | Results Presentation Deck | 40 slidesMaersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
26
Includes a footnote regarding restricted cash and bank balances.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
27
Includes a footnote regarding the cancellation of treasury shares.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
28
Includes footnotes regarding share capital increase and sale of Dansk Supermarked Group.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
29
Maersk | Results Presentation Deck | 40 slidesMaersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
30
The table provides a breakdown of financial performance by business segment (Maersk Line, Oil, Terminals, Drilling, Supply Service, Tankers, Damco, Sviter).Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
31
Financial data in USD million.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
32
Data is presented in USD million.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
33
Data presented in USD million.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
34
Amounts in USD million.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
35
Includes narrative explanation of Dansk Bank divestment and Dansk Supermarked Group classification.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
38
Contains three distinct tables: development in number of shares, development in holding of own shares, and basis for calculating EPS.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
39
Standard accounting policy disclosure page for Maersk Group Q3 2015 interim report.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
40
Standard corporate colophon page listing board members, committees, auditors, and production credits.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
01
MAIA Biotechnology | Investor Presentation Deck | 35 slidesMAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
02
MAIA Biotechnology | Investor Presentation Deck | 35 slidesMAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
03
MAIA Biotechnology | Investor Presentation Deck | 35 slidesMAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
04
The slide outlines clinical trial progress (THIO-101, 102, 103), regulatory designations, and intellectual property status.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
05
The slide uses a Gantt-style visualization to track drug development progress.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide uses a chromosome icon for the lead asset and a fast-forward icon for the pipeline.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
MAIA Biotechnology | Investor Presentation Deck | 35 slidesMAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
MAIA Biotechnology | Investor Presentation Deck | 35 slidesMAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide illustrates the biological interaction between THIO (telomere targeting) and CPIs (checkpoint inhibitors) to induce tumor cell death.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
Slide highlights a strategic partnership/validation event.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Why Now1 hit
12
The slide outlines a clinical trial process flow from initial NSCLC 2L+ patient entry through randomization to expansion.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Why Now1 hit
13
The slide uses a bulleted list to present clinical trial safety findings.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit